32 results on '"Fogel, Evan L."'
Search Results
2. ERCP for Gallstone Pancreatitis.
- Author
-
Fogel, Evan L. and Sherman, Stuart
- Subjects
- *
PANCREATITIS , *ENDOSCOPIC retrograde cholangiopancreatography , *PATHOLOGICAL physiology , *HEMORRHAGE , *INTESTINAL perforation - Abstract
The article explores the case of a 74-year-old man diagnosed with acute pancreatitis who underwent selective endoscopic retrograde cholangiopancreatography (ERCP). The pathophysiology of gallstone pancreatitis, as well as the impact of ERCP treatment are discussed. Adverse side-effects of the ERCP are presented, which includes pancreatitis, bleeding, ductal or intestinal perforation and cardiopulmonary events.
- Published
- 2014
- Full Text
- View/download PDF
3. Clinical utility of stent cytology for the diagnosis of pancreaticobiliary neoplasms
- Author
-
Devereaux, Benedict M., Fogel, Evan L., Bucksot, Lois, Shelly, Lee A., Lehman, Glen A., and Sherman, Stuart
- Subjects
- *
TUMOR diagnosis , *ENDOSCOPIC retrograde cholangiopancreatography - Abstract
: ObjectiveERCP is frequently the technique of choice for the diagnosis and palliative treatment of pancreaticobiliary neoplasms. The sensitivity of tissue sampling techniques has been disappointing. Two small series have reported a high diagnostic yield from cytological examination of cellular debris from removed biliary stents. The aim of this study was to determine the clinical utility of stent cytology for the diagnosis of biliary and pancreatic neoplasia.: MethodsPatients who had biliary or pancreatic stents removed at ERCP and evaluated cytologically were the subjects of this study. Stents were scraped and washed, and the cellular debris was examined cytologically and recorded as positive, atypical, or negative. Patient demographics, ductal stricture, and stent characteristics were recorded.: ResultsBetween January, 1994 and January, 2001 a total of 126 biliary stents from 101 patients (61 male, 40 female, mean age 62 yr) and 29 pancreatic stents from 19 patients (seven male, 12 female, mean age 58 yr) were examined. The sensitivity, specificity, positive predictive value, and negative predictive value of biliary and pancreatic stents for the diagnosis of neoplasia were: 11%, 100%, 100%, 53%, and 25%, 100%, 100%, 77.8%, respectively. The sensitivity improved slightly if all degrees of atypia were considered positive for neoplasia. The mean duration of stent placement was 93.6 days for biliary stents and 43.5 days for pancreatic stents.: ConclusionsBiliary and pancreatic stent cytology has limited clinical utility in the diagnosis of pancreaticobiliary neoplasia, owing to poor sensitivity. In addition, the time lag between stent placement and removal for cytologic examination further limits its contribution to patient management. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
4. Endoscopic pancreatic necrosectomy.
- Author
-
Fogel, Evan and Fogel, Evan L
- Subjects
- *
ENDOSCOPIC surgery , *PANCREATIC surgery , *PANCREATITIS , *NECROSIS , *HEALTH outcome assessment , *MORTALITY , *OPERATIVE surgery , *DEBRIDEMENT , *ENDOSCOPIC ultrasonography , *MEDICAL protocols , *NECROTIZING pancreatitis , *MEDICAL suction , *DIGESTIVE system endoscopic surgery - Abstract
Traditionally, patients with symptomatic sterile pancreatic necrosis or infected necrosis have been managed by open surgical debridement and removal of necrotic tissue. Within the last decade, however, reports of endoscopic pancreatic necrosectomy, an alternative minimally invasive approach, have demonstrated high success rates and low mortality rates. This report describes the indications, technique, and study outcome data of the procedure. While our experience with this technique has recently increased, better selection criteria are needed to identify patients who are most suitable for endoscopic therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
5. Comparative Risks of Post-ERCP Adverse Events in Patients with Asymptomatic and Symptomatic Choledocholithiasis: A Systematic Review and Meta-Analysis.
- Author
-
Obaitan, Itegbemie, Mohamed, Mouhand F. H., Beran, Azizullah, Rosenheck, Michael, Obomanu, Elvis T., Berzin, Tyler M., Ramai, Daryl, Wehbe, Hisham, Aziz, Muhammad, Mahendraker, Neetu, Al-Haddad, Mohammad, Easler, Jeffrey J., and Fogel, Evan L.
- Subjects
- *
ASYMPTOMATIC patients , *GALLSTONES , *ENDOSCOPIC retrograde cholangiopancreatography , *SCIENCE databases , *WEB databases - Abstract
Background and Aims: Endoscopic retrograde cholangiopancreatography (ERCP) is the standard of care for the management of choledocholithiasis but carries risk of complications which may result in significant morbidity and mortality. While currently available guidelines endorse the use of ERCP for the management of symptomatic common bile duct stones, the need for ERCP in incidentally found asymptomatic choledocholithiasis is more controversial, and practice varies on a geographic and institutional level. This systematic review and meta-analysis is conducted to compare post-ERCP adverse events between asymptomatic and symptomatic choledocholithiasis patients. Methods: We searched PubMed/Embase/Web of Science databases to include all studies comparing post-ERCP outcomes between asymptomatic and symptomatic choledocholithiasis patients. The primary outcome was post-ERCP pancreatitis (PEP), while secondary outcomes included post-ERCP cholangitis, bleeding, and perforation. We calculated pooled risk ratios (RR) and 95% confidence intervals (CIs) using the Mantel–Haenszel method within a random-effect model. Results: Our analysis included six observational studies, totaling 2,178 choledocholithiasis patients (392 asymptomatic and 1786 symptomatic); 53% were female. Asymptomatic patients exhibited a higher risk of PEP compared with symptomatic patients (11.7% versus 4.8%; RR 2.59, 95% CI 1.56–4.31, p ≤ 0.001). No significant difference was observed in post-ERCP cholangitis, bleeding, or perforation rates between the two groups. Conclusions: Asymptomatic patients with choledocholithiasis appear to have a higher risk of PEP than symptomatic patients, while the risk of other post-ERCP adverse events is similar between the two groups. Interventional endoscopists should thoroughly discuss potential adverse events (particularly PEP) with asymptomatic patients before performing ERCP and utilize PEP-prevention measures more liberally in this subgroup of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Contemporary Outcomes of Transduodenal Sphincteroplasty: the Importance of Surgical Quality.
- Author
-
Walia, Sonal, Zaidi, Mohammad Y., McGuire, Sean, Milam, Claire, Fogel, Evan L., Sherman, Stuart, Lehman, Glen, Pitt, Henry A., Nakeeb, Attila, Schmidt, C. Max, House, Michael G., Ceppa, Eugene P., Timsina, Lava, and Zyromski, Nicholas J.
- Subjects
- *
SURGICAL complications , *TREATMENT effectiveness , *SPHINCTERS , *CHOLANGIOGRAPHY - Abstract
Background: Sphincter of Oddi dysfunction (SOD) is managed primarily by endoscopic sphincterotomy (ES); however, surgical transduodenal sphincteroplasty (TDS) is a treatment option for select patients. In our high-volume pancreatico-biliary practice, we have observed variable outcomes among TDS patients; therefore, we sought to determine preoperative predictors of durable improvement in quality of life. Methods: SOD patients treated by TDS between January 2006 and December 2015 were studied. The primary outcome measure was long-term changes in quality of life after sphincteroplasty. The secondary outcome measure examined postoperative outcomes, including postoperative complications, need for repeat procedures, and readmission rates. Perioperative data were abstracted, and the SF-36 quality-of-life (QoL) survey was administered. Standard statistical analysis included non-parametric methods to examine bivariate associations. Results: Eighty-eight patients had an average follow-up duration of 6.7 (± 2.9) years. Thirty (34%) patients were naïve to endoscopic therapy. Patients with prior endoscopy averaged 2.1 procedures (range 1 to 13) prior to surgery. Perioperative morbidity was 27%; one postoperative death was caused by severe acute pancreatitis. Twenty-nine (33%) patients required subsequent biliary-pancreatic procedures. QoL analysis from available patients showed that 66% were improved or much improved. With multivariable analysis including SOD type and prior endoscopic instrumentation, freedom from surgical complication was the only variable that correlated significantly with a good outcome (p < 0.02). Conclusion: Surgical transduodenal sphincteroplasty provides durable symptom management for select patients with sphincter of Oddi dysfunction. Minimizing surgical complications optimizes long-term outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Timing of ERCP after extracorporeal shock wave lithotripsy for large main pancreatic duct stones.
- Author
-
Saleem, Nasir, Patel, Feenalie, Watkins, James L., McHenry, Lee, Easler, Jeffrey J., Fogel, Evan L., Gromski, Mark A., Lehman, Glen A., Sherman, Stuart, Tong, Yan, and Bick, Benjamin L.
- Abstract
Background and aims: Extracorporeal shock wave lithotripsy (ESWL) is performed to fragment large main pancreatic duct (MPD) stones in symptomatic patients. Subsequent endoscopic retrograde cholangiopancreatography (ERCP) is often performed to clear the stone fragments. Edema of surrounding tissue after ESWL theoretically affects the ability to perform ERCP. However, the optimal timing of ERCP after ESWL is not clearly defined. The aim of this study is to determine the efficacy and safety of same-day ERCP after ESWL and to determine if the timing of ERCP after ESWL affects outcomes. Methods: This is a retrospective study of consecutive patients from January, 2013 to September, 2019 who received ESWL for MPD stones at our center. Included patients received subsequent same-day ERCP under the same general anesthesia session or later session ERCP (1–30 days after ESWL). Demographics, anatomical findings, history, and outcomes were collected. Success was defined as complete or near complete (> 80%) stone fragmentation with clearance. Results: 218 patients were treated with ESWL and subsequent ERCP. 133 (61.0%) received ERCP on the same day immediately after ESWL, while 85 (39.0%) returned for ERCP at a later day (median 3.0 days after ESWL). Baseline characteristics demonstrated patients who received same-day ERCP had a higher rate of pain at baseline (94.7% vs 87.1%, p = 0.045). Main outcomes demonstrated an overall successful MPD stone clearance rate of 90.4%, with similar rates between same-day ERCP and later session ERCP (91.7% vs 88.2%, p = 0.394). Additionally, successful cannulation at ERCP, adverse events, and post-procedure admission rates were similar. Conclusions: Delaying ERCP to allow peripancreatic tissue recovery after ESWL does not affect outcomes. Same-day ERCP after ESWL is safe and effective. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Diagnosis of chronic pancreatitis using semi-quantitative MRI features of the pancreatic parenchyma: results from the multi-institutional MINIMAP study.
- Author
-
Tirkes, Temel, Yadav, Dhiraj, Conwell, Darwin L., Territo, Paul R., Zhao, Xuandong, Persohn, Scott A., Dasyam, Anil K., Shah, Zarine K., Venkatesh, Sudhakar K., Takahashi, Naoki, Wachsman, Ashley, Li, Liang, Li, Yan, Pandol, Stephen J., Park, Walter G., Vege, Santhi Swaroop, Hart, Phil A., Topazian, Mark, Andersen, Dana K., and Fogel, Evan L.
- Subjects
- *
CHRONIC pancreatitis , *MAGNETIC resonance imaging , *PANCREATIC duct , *PANCREAS , *LOGISTIC regression analysis , *DIAGNOSIS , *LONGITUDINAL method - Abstract
Purpose: To determine the diagnostic performance of parenchymal MRI features differentiating CP from controls. Methods: This prospective study performed abdominal MRI scans at seven institutions, using 1.5 T Siemens and GE scanners, in 50 control and 51 definite CP participants, from February 2019 to May 2021. MRI parameters included the T1-weighted signal intensity ratio of the pancreas (T1 score), arterial-to-venous enhancement ratio (AVR) during venous and delayed phases, pancreas volume, and diameter. We evaluated the diagnostic performance of these parameters individually and two semi-quantitative MRI scores derived using logistic regression: SQ-MRI Model A (T1 score, AVR venous, and tail diameter) and Model B (T1 score, AVR venous, and volume). Results: When compared to controls, CP participants showed a significantly lower mean T1 score (1.11 vs. 1.29), AVR venous (0.86 vs. 1.45), AVR delayed (1.07 vs. 1.57), volume (54.97 vs. 80.00 ml), and diameter of the head (2.05 vs. 2.39 cm), body (2.25 vs. 2.58 cm), and tail (1.98 vs. 2.51 cm) (p < 0.05 for all). AUCs for these individual MR parameters ranged from 0.66 to 0.79, while AUCs for the SQ-MRI scores were 0.82 and 0.81 for Model A (T1 score, AVR venous, and tail diameter) and Model B (T1 score, AVR venous, and volume), respectively. After propensity-matching adjustments for covariates, AUCs for Models A and B of the SQ-MRI scores increased to 0.92 and 0.93, respectively. Conclusion: Semi-quantitative parameters of the pancreatic parenchyma, including T1 score, enhancement ratio, pancreas volume, diameter and multi-parametric models combining these parameters are helpful in diagnosis of CP. Longitudinal analyses including more extensive population are warranted to develop new diagnostic criteria for CP. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. ERCP for gallstone pancreatitis.
- Author
-
Fogel, Evan L and Sherman, Stuart
- Published
- 2014
- Full Text
- View/download PDF
10. ERCP for Gallstone Pancreatitis.
- Author
-
Fogel, Evan L. and Sherman, Stuart
- Subjects
- *
ENDOSCOPIC retrograde cholangiopancreatography , *PANCREATITIS , *GALLSTONES - Abstract
A response from the authors of the article "ERCP for gallstone pancreatitis" in the January 9, 2014 issue is presented.
- Published
- 2014
- Full Text
- View/download PDF
11. Development of a Clinical Prediction Model for Diabetes in Chronic Pancreatitis: The PREDICT3c Study.
- Author
-
Jeon, Christie, Hart, Phil A., Li, Liang, Yang, Yunlong, Chang, Eleanor, Bellin, Melena D., Fisher, William E., Fogel, Evan L., Forsmark, Christopher E., Park, Walter G., Van Den Eeden, Stephen K., Vege, Santhi Swaroop, Serrano, Jose, Whitcomb, David C., Andersen, Dana K., Conwell, Darwin L., Yadav, Dhiraj, and Goodarzi, Mark O.
- Subjects
- *
EXOCRINE pancreatic insufficiency , *CHRONIC pancreatitis , *TYPE 2 diabetes , *RECEIVER operating characteristic curves , *PREDICTION models - Abstract
Objective: Diabetes that arises from chronic pancreatitis (CP) is associated with increased morbidity and mortality. Methods to predict which patients with CP are at greatest risk for diabetes are urgently needed. We aimed to examine independent risk factors for diabetes in a large cohort of patients with CP.Research Design and Methods: This cross-sectional study comprised 645 individuals with CP enrolled in the PROCEED study, of whom 276 had diabetes. We conducted univariable and multivariable regression analyses of potential risk factors for diabetes. Model performance was assessed by area under the receiver operating characteristic curve (AUROC) analysis, and accuracy was evaluated by cross validation. Exploratory analyses were stratified according to the timing of development of diabetes relative to the diagnosis of pancreatitis.Results: Independent correlates of diabetes in CP included risk factors for type 2 diabetes (older age, overweight/obese status, male sex, non-White race, tobacco use) as well as pancreatic disease-related factors (history of acute pancreatitis complications, nonalcoholic etiology of CP, exocrine pancreatic dysfunction, pancreatic calcification, pancreatic atrophy) (AUROC 0.745). Type 2 diabetes risk factors were predominant for diabetes occurring before pancreatitis, and pancreatic disease-related factors were predominant for diabetes occurring after pancreatitis.Conclusions: Multiple factors are associated with diabetes in CP, including canonical risk factors for type 2 diabetes and features associated with pancreatitis severity. This study lays the groundwork for the future development of models integrating clinical and nonclinical data to identify patients with CP at risk for diabetes and identifies modifiable risk factors (obesity, smoking) on which to focus for diabetes prevention. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
12. Quantitative MRI of chronic pancreatitis: results from a multi-institutional prospective study, magnetic resonance imaging as a non-invasive method for assessment of pancreatic fibrosis (MINIMAP).
- Author
-
Tirkes, Temel, Yadav, Dhiraj, Conwell, Darwin L., Territo, Paul R., Zhao, Xuandong, Persohn, Scott A., Dasyam, Anil K., Shah, Zarine K., Venkatesh, Sudhakar K., Takahashi, Naoki, Wachsman, Ashley, Li, Liang, Li, Yan, Pandol, Stephen J., Park, Walter G., Vege, Santhi S., Hart, Phil A., Topazian, Mark, Andersen, Dana K., and Fogel, Evan L.
- Subjects
- *
MAGNETIC resonance imaging , *CHRONIC pancreatitis , *PANCREATITIS , *SCANNING systems , *EPIDEMIOLOGY - Abstract
Purpose: To determine if quantitative MRI techniques can be helpful to evaluate chronic pancreatitis (CP) in a setting of multi-institutional study. Methods: This study included a subgroup of participants (n = 101) enrolled in the Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) study (NCT03099850) from February 2019 to May 2021. MRI was performed on 1.5 T using Siemens and GE scanners at seven clinical centers across the USA. Quantitative MRI parameters of the pancreas included T1 relaxation time, extracellular volume (ECV) fraction, apparent diffusion coefficient (ADC), and fat signal fraction. We report the diagnostic performance and mean values within the control (n = 50) and CP (n = 51) groups. The T1, ECV and fat signal fraction were combined to generate the quantitative MRI score (Q-MRI). Results: There was significantly higher T1 relaxation time; mean 669 ms (± 171) vs. 593 ms (± 82) (p = 0.006), ECV fraction; 40.2% (± 14.7) vs. 30.3% (± 11.9) (p < 0.001), and pancreatic fat signal fraction; 12.2% (± 5.5) vs. 8.2% (± 4.4) (p < 0.001) in the CP group compared to controls. The ADC was similar between groups (p = 0.45). The AUCs for the T1, ECV, and pancreatic fat signal fraction were 0.62, 0.72, and 0.73, respectively. The composite Q-MRI score improved the diagnostic performance (cross-validated AUC: 0.76). Conclusion: Quantitative MR parameters evaluating the pancreatic parenchyma (T1, ECV fraction, and fat signal fraction) are helpful in the diagnosis of CP. A Q-MRI score that combines these three MR parameters improves diagnostic performance. Further studies are warranted with larger study populations including patients with acute and recurrent acute pancreatitis and longitudinal follow-ups. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Microbiology of bile aspirates obtained at ERCP in patients with suspected acute cholangitis.
- Author
-
Gromski, Mark A., Gutta, Aditya, Lehman, Glen A., Tong, Yan, Fogel, Evan L., Watkins, James L., Easler, Jeffrey J., Bick, Benjamin L., McHenry, Lee, Beeler, Cole, Relich, Ryan F., Schmitt, Bryan H., and Sherman, Stuart
- Subjects
- *
ANTIBIOTICS , *CIPROFLOXACIN , *ENTEROCOCCUS , *CHOLANGITIS , *BILE , *RETROSPECTIVE studies , *ENDOSCOPIC retrograde cholangiopancreatography - Abstract
Background: The cornerstone of treatment for acute cholangitis is source control with biliary drainage and early antibiotics. The primary aim of this study was to describe the microbiology of bile aspirate pathogens obtained at the time of endoscopic retrograde cholangiopancreatography (ERCP) in patients suspected of having acute cholangitis.Methods: In this single-center retrospective study, patients were included if a bile aspirate was collected at ERCP for suspicion of acute cholangitis, from 1 January 2010 to 31 December 2016.Results: There were 721 ERCP procedures for suspected acute cholangitis with bile culture results, with 662 positive bile cultures (91.8 %). Pathogens included: Enterococcus species (spp.) 448 (67.7 %); Klebsiella spp. 295 (44.6 %); Escherichia coli 269 (40.6 %); Pseudomonas spp. 52 (7.9 %); and anaerobes 64 (9.7 %). Susceptibility of Klebsiella pneumoniae and E.coli isolates to ciprofloxacin was 88 % and 64 %, respectively. Extended-spectrum beta-lactamases and carbapenem resistance were found in 7.9 % and 3.6 % of Enterobacteriaceae, respectively. There were 437 concurrent blood cultures, of which 174 were positive (39.8 % of cultures drawn). Prior biliary endoscopic sphincterotomy (ES) was evident in 459 ERCP cases (63.7 %), and was associated with increased frequency of Klebsiella spp., Pseudomonas aeruginosa, Enterobacter spp., and Enterococcus spp. Prior biliary ES significantly increased the probability of vancomycin-resistant Enterococcus (VRE).Conclusions: The vast majority of bile cultures (91.8 %) were positive. The susceptibilities of E.coli and K.pneumoniae to ciprofloxacin are lower than historically noted. A notable portion of cultures contained pathogenic drug-resistant organisms. Prior biliary ES is associated with a higher frequency of certain organisms and higher frequency of VRE. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
14. T1 signal intensity ratio of the pancreas as an imaging biomarker for the staging of chronic pancreatitis.
- Author
-
Tirkes, Temel, Dasyam, Anil K., Shah, Zarine K., Fogel, Evan L., Vege, Santhi Swaroop, Li, Liang, Li, Shuang, Chang, Stephanie T., Farinas, Carlos A., Grajo, Joseph R., Mawad, Kareem, Takahashi, Naoki, Venkatesh, Sudhakar K., Wachsman, Ashley, Fisher, William E., Forsmark, Christopher E., Hart, Phil A., Pandol, Stephen J., Park, Walter G., and Van Den Eeden, Stephen K.
- Subjects
- *
PANCREAS , *BIOMARKERS , *CHRONIC pancreatitis , *MAGNETIC resonance imaging , *PANCREATITIS - Abstract
Purpose: Our purpose was to validate the T1 SIR (T1 score) as an imaging biomarker for the staging of CP in a large, multi-institutional, prospective study. Methods: The prospective study population included 820 participants enrolled in the PROCEED study from nine clinical centers between June 2017 and December 2021. A radiologist at each institution used a standardized method to measure the T1 signal intensity of the pancreas and the reference organs (spleen, paraspinal muscle, liver), which was used to derive respective T1 scores. Participants were stratified according to the seven mechanistic stages of chronic pancreatitis (MSCP 0–6) based on their clinical history, MRCP, and CT findings. Results: The mean pancreas-to-spleen T1 score was 1.30 in participants with chronic abdominal pain, 1.22 in those with acute or recurrent acute pancreatitis, and 1.03 in definite CP. After adjusting for covariates, we observed a linear, progressive decline in the pancreas-to-spleen T1 score with increasing MSCP from 0 to 6. The mean pancreas-to-spleen T1 scores were 1.34 (MSCP 0), 1.27 (MSCP 1), 1.21 (MSCP 2), 1.16 (MSCP 3), 1.18 (MSCP 4), 1.12 (MSCP 5), and 1.05 (MSCP 6) (p < 0.0001). The pancreas-to-liver and pancreas-to-muscle T1 scores showed less linear trends and wider confidence intervals. Conclusion: The T1 score calculated by SIR of the pancreas-to-spleen shows a negative linear correlation with the progression of chronic pancreatitis. It holds promise as a practical imaging biomarker in evaluating disease severity in clinical research and practice. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Histopathologic correlation of pancreatic fibrosis with pancreatic magnetic resonance imaging quantitative metrics and Cambridge classification.
- Author
-
Tirkes, Temel, Saeed, Omer A., Osuji, Vitalis C., Kranz, Carsyn E., Roth, Adam A., Patel, Aashish A., Zyromski, Nicholas J., and Fogel, Evan L.
- Subjects
- *
CYSTIC fibrosis , *MAGNETIC resonance imaging , *HISTOPATHOLOGY , *RANK correlation (Statistics) , *PANCREAS - Abstract
Purpose: To determine the correlation of the T1-weighted signal intensity ratio (T1 SIR, or T1 Score) and arterial-to-delayed venous enhancement ratio (ADV ratio) of the pancreas with pancreatic fibrosis on histopathology. Methods: Sixty consecutive adult CP patients who had an MRI/MRCP study prior to pancreatic surgery were analyzed. Three blinded observers measured T1 SIR of pancreas to spleen (T1 SIR p/s), pancreas-to-paraspinal muscle (T1 SIR p/m), ADV ratio, and Cambridge grade. Histopathologic grades were given by a gastrointestinal pathologist using Ammann's fibrosis score. Statistical analysis included Spearman's correlation coefficient of the T1 SIR, ADV ratio, Cambridge grade with the fibrosis score, and weighted kappa for interobserver agreement. Results: The study population included 31 female and 29 male patients, with an average age of 52.1 (26–78 years). Correlations between fibrosis score and T1 SIR p/s, T1 SIR p/m, and ADV ratio were ρ = − 0.54 (p = 0.0001), ρ = − 0.19 (p = 0.19), and ρ = − 0.39 (p = 0.003), respectively. The correlation of Cambridge grade with fibrosis score was ρ = 0.26 (p = 0.07). There was substantial interobserver agreement (weighted kappa) for T1 SIR p/s (0.78), T1 SIR p/m (0.71), and ADV ratio (0.64). T1 SIR p/s of ≤ 1.20 provided a sensitivity of 74% and specificity of 50% (AUC: 0.74), while ADV ratio of ≤ 1.10 provided a sensitivity of 75% and specificity of 55% (AUC: 0.68) to detect a fibrosis score of ≥ 6. Conclusion: There is a moderate negative correlation between the T1 Score (SIR p/s) and ADV ratio with pancreatic fibrosis and a substantial interobserver agreement. These parenchymal metrics show a higher correlation than the Cambridge grade. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. A comparative study between single-operator pancreatoscopy with intraductal lithotripsy and extracorporeal shock wave lithotripsy for the management of large main pancreatic duct stones.
- Author
-
Bick, Benjamin L., Patel, Feenalie, Easler, Jeffrey J., Tong, Yan, Watkins, James L., McHenry, Lee, Lehman, Glen, Fogel, Evan L., Gromski, Mark A., and Sherman, Stuart
- Subjects
- *
EXTRACORPOREAL shock wave lithotripsy , *PANCREATIC duct , *ENDOSCOPIC surgery , *COMPARATIVE studies , *LASER peening - Abstract
Background and aims: Endoscopic management of large main pancreatic ductal (MPD) stones often require treatment with lithotripsy. Extracorporeal shock wave lithotripsy (ESWL) has been the mainstay therapy, and single-operator pancreatoscopy with intraductal (intracorporeal) lithotripsy (SOPIL) is an emerging technique. However, no comparative studies between these techniques exist. We therefore aimed to compare ESWL to SOPIL for the treatment of large MPD stones. Methods: This is a retrospective cohort study comparing patients who were treated with ESWL or SOPIL from September 2013 to September 2019 at a single tertiary center. Logistic regression was performed to identify factors associated with technical success and efficient stone clearance (≤ 2 procedures to clear stones). Results: There were 240 patients who were treated with ESWL and 18 treated with SOPIL. The overall technical success rate of stone clearance was 224/258 (86.8%), which was similar between the ESWL and SOPIL groups (86.7% vs 88.9%, p = 1.000). A SOPIL approach required fewer total procedures (1.6 ± 0.6 vs 3.1 ± 1.5, p < 0.001) and less aggregate procedure time (101.6 ± 68.2 vs 191.8 ± 111.6 min, p = 0.001). Adverse event rates were similar between the groups (6.3% vs 5.6%, p = 1.000). The use of SOPIL was independently associated with greater efficiency compared to ESWL (OR 5.241 [1.348–20.369], p = 0.017). Stone size > 10 mm was associated with less efficient stone clearance (OR 0.484 [0.256–0.912], p = 0.025). Conclusion: Both ESWL and SOPIL are safe and effective endoscopic adjunct modalities for treating large pancreatic duct stones. SOPIL is an emerging alternative to ESWL that is potentially more efficient for lithotripsy and MPD stone clearance. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Multicenter Randomized Trial of 10-French versus 11.5-French Plastic Stents for Malignant Biliary Obstruction.
- Author
-
Wagh, Mihir S., de Bellis, Mario, Fogel, Evan L., Frakes, James T., Johanson, John F., Qaseem, Tahir, Howell, Douglas A., Lehman, Glen A., and Sherman, Stuart
- Subjects
- *
BILIOUS diseases & biliousness , *SURGICAL stents , *RANDOMIZED controlled trials , *MEDICAL centers , *HEALTH outcome assessment , *CONTROL groups , *LONGITUDINAL method - Abstract
Background. There is little prospective data on whether bigger plastic stents are better for patients with malignant biliary obstruction with jaundice. Goals. Multicenter prospective study to compare technical success, clinical response, stent occlusion, and patient survival in patients with malignant biliary obstruction randomized to 10-French or 11.5-French plastic stent. Study. Patients with malignant biliary obstruction were randomized to 10-French or 11.5-French biliary stents. Patients were prospectively assessed for stent occlusion, stent-related interventions, hospital stay, and change in bilirubin. Main outcome measurements included technical success, clinical response, rates of stent occlusion, and survival. Results. 234 patients (47 hilar and 187 common bile duct strictures) were randomized. Outcomes were similar for the 10-French and 11.5-French groups (technical success 99.1% versus 97.4%, p = 0.37). Overall, median stent survival was 213 days, but there was no statistically significant difference in stent survival between 10-French and 11.5-French stents (149 versus 258 days, p = 0.16). Stent survival was significantly longer when placed for common bile duct versus hilar strictures (231 versus 115 days, p = 0.049). Conclusions. The theoretical advantage of improved bile flow for the 11.5-French stent does not translate into more prolonged patency, better clinical response, and longer patient survival than the 10-French stent. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
18. Combined Versus Separate Sessions of Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for the Diagnosis and Management of Pancreatic Ductal Adenocarcinoma with Biliary Obstruction.
- Author
-
Purnak, Tugrul, El Hajj, Ihab I., Sherman, Stuart, Fogel, Evan L., McHenry, Lee, Lehman, Glen, Gromski, Mark A., Al-Haddad, Mohammad, DeWitt, John, Watkins, James L., and Easler, Jeffrey J.
- Subjects
- *
ENDOSCOPIC retrograde cholangiopancreatography , *ENDOSCOPIC ultrasonography , *PANCREATIC duct , *ADENOCARCINOMA - Abstract
Background: A single-procedure session combining EUS and ERCP (EUS/ERCP) for tissue diagnosis and biliary decompression for pancreatic duct adenocarcinoma (PDAC) is technically feasible. While EUS/ERCP may offer expedience and convenience over an approach of separate procedures sessions, the technical success and risk for complications of a combined approach is unclear. Aims: Compare the effectiveness and safety of EUS/ERCP versus separate session approaches for PDAC. Methods: Study patients (2010–2015) were identified within our ERCP database. Patients were analyzed in three groups based on approach: Group A: Single-session EUS-FNA and ERCP (EUS/ERCP), Group B: EUS-FNA followed by separate, subsequent ERCP (EUS then ERCP), and Group C: ERCP with/without separate EUS (ERCP ± EUS). Rates of technical success, number of procedures, complications, and time to initiation of PDAC therapies were compared between groups. Results: Two hundred patients met study criteria. EUS/ERCP approach (Group A) had a longer index procedure duration (median 66 min, p = 0.023). No differences were observed between Group A versus sequential procedure approaches (Groups B and C) for complications (p = 0.109) and success of EUS-FNA (p = 0.711) and ERCP (p = 0.109). Subgroup analysis (> 2 months of follow-up, not referred to hospice, n = 126) was performed. No differences were observed for stent failure (p = 0.307) or need for subsequent procedures (p = 0.220). EUS/ERCP (Group A) was associated with a shorter time to initiation of PDAC therapies (mean, 25.2 vs 42.7 days, p = 0.046). Conclusions: EUS/ERCP approach has comparable rates of success and complications compared to separate, sequential approaches. An EUS/ERCP approach equates to shorter time interval to initiation of PDAC therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. T1 mapping for the diagnosis of early chronic pancreatitis: correlation with Cambridge classification system.
- Author
-
Cheng, Monica, Gromski, Mark A, Fogel, Evan L, DeWitt, John M, Patel, Aashish A, and Tirkes, Temel
- Subjects
- *
CHRONIC pancreatitis , *EARLY diagnosis , *MAGNETIC resonance , *MEDICAL protocols , *OPTICAL scanners , *SOIL classification - Abstract
This study aims to determine if T1 relaxation time of the pancreas can detect parenchymal changes in early chronic pancreatitis (CP). This study retrospectively analyzed 42 patients grouped as no CP (Cambridge 0; n = 21), equivocal (Cambridge 1; n = 12) or mild CP (Cambridge 2; n = 9) based on magnetic resonance cholangiopancreatography findings using the Cambridge classification as the reference standard. Unenhanced T1 maps were acquired using a three-dimensional dual flip-angle gradient-echo technique on the same 1.5 T scanner with the same imaging parameters. There was no significant difference between the T1 relaxation times of Cambridge 0 and 1 group (p = 0.58). There was a significant difference (p = 0.0003) in the mean T1 relaxation times of the pancreas between the combined Cambridge 0 and 1 (mean = 639 msec, 95% CI: 617, 660) and Cambridge 2 groups (mean = 726 msec, 95% CI: 692, 759). There was significant difference (p = 0.0009) in the mean T1 relaxation times of the pancreas between the Cambridge 0 (mean = 636 msec, 95% CI: 606, 666) and Cambridge 2 groups (mean = 726 msec, 95% CI: 692,759) as well as between Cambridge 1 (mean = 643 msec, 95% CI: 608, 679) and Cambridge 2 groups (mean = 726 msec, 95% CI: 692,759) (p = 0.0017). Bland–Altman analysis showed measurements of one reader to be marginally higher than the other by 15.7 msec (2.4%, p = 0.04). T1 mapping is a practical method capable of quantitatively reflecting morphologic changes even in the early stages of chronic pancreatitis, and demonstrates promise for future implementation in routine clinical imaging protocols. T1 mapping can distinguish subtle parenchymal changes seen in early stage CP, and demonstrates promise for implementation in routine imaging protocols for the diagnosis of CP. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. Magnetic resonance imaging as a non-invasive method for the assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer.
- Author
-
Tirkes, Temel, Yadav, Dhiraj, Conwell, Darwin L., Territo, Paul R., Zhao, Xuandong, Venkatesh, Sudhakar K., Kolipaka, Arunark, Li, Liang, Pisegna, Joseph R., Pandol, Stephen J., Park, Walter G., Topazian, Mark, Serrano, Jose, and Fogel, Evan L.
- Subjects
- *
CYSTIC fibrosis , *MAGNETIC resonance imaging , *CHRONIC pancreatitis , *DIFFUSION magnetic resonance imaging , *DIAGNOSTIC imaging , *PANCREATIC cancer - Abstract
Characteristic features of chronic pancreatitis (CP) may be absent on standard imaging studies. Quantitative Magnetic Resonance Imaging (MRI) techniques such as T1 mapping, extracellular volume (ECV) fraction, diffusion-weighted imaging (DWI) with apparent diffusion coefficient map (ADC), MR elastography (MRE), and T1-weighted signal intensity ratio (SIR) have shown promise for the diagnosis and grading severity of CP. However, radiologists still use the Cambridge classification which is based on traditional ductal imaging alone. There is an urgent need to develop new diagnostic criteria that incorporate both parenchymal and ductal features of CP seen by MRI/MRCP. Designed to fulfill this clinical need, we present the MINIMAP study, which was funded in September 2018 by the National Institutes of Health. This is a comprehensive quantitative MR imaging study which will be performed at multiple institutions in well-phenotyped CP patient cohorts. We hypothesize that quantitative MRI/MRCP features can serve as valuable non-invasive imaging biomarkers to detect and grade CP. We will evaluate the role of T1 relaxometry, ECV, T1-weighted gradient echo SIR, MRE, arteriovenous enhancement ratio, ADC, pancreas volume/atrophy, pancreatic fat fraction, ductal features, and pancreatic exocrine output following secretin stimulation in the assessment of CP. We will attempt to generate a multi-parametric pancreatic tissue fibrosis (PTF) scoring system. We anticipate that a quantitative scoring system may serve as a biomarker of pancreatic fibrosis; hence this imaging technique can be used in clinical practice as well as clinical trials to evaluate the efficacy of agents which may slow the progression or reverse measures of CP. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
21. Contemporary Outcomes of Transduodenal Sphincteroplasty: The Importance of Surgical Quality.
- Author
-
Zaidi, Mohammad Y., Milam, Claire, Fogel, Evan L., Sherman, Stuart, Pitt, Henry A., Nakeeb, Attila, Max, C., Schmidt, M., House, Michael G., Ceppa, Eugene P., and Zyromski, Nicholas J.
- Subjects
- *
SPHINCTER of Oddi , *SPHINCTERECTOMY , *HEALTH outcome assessment , *ENDOSCOPIC surgery , *QUALITY of life , *BILIARY tract - Published
- 2017
- Full Text
- View/download PDF
22. Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents.
- Author
-
Hyoung-Chul Oh, El Hajj, Ihab I., Easler, Jeffrey J., Watkins, James, Fogel, Evan L., McHenry, Lee, Lehman, Glen A., Jung Sik Choi, Hyun Kang, and Sherman, Stuart
- Subjects
- *
HEMORRHAGE treatment , *ENDOSCOPIC retrograde cholangiopancreatography , *PLATELET aggregation inhibitors , *ENDOSCOPIC surgery , *MEDICAL balloons - Abstract
Background/Aims: This study aimed to determine the risk of post-endoscopic retrograde cholangiopancreatography (post-ERCP) bleeding among patients taking antiplatelet agents (APAs), particularly in the era of multiple APAs. Methods: The primary outcomes were the frequency, type, and severity of ERCP-related bleeding according to the use of APAs. Results: The frequencies of post-ERCP bleeding among the four different groups were 16 of 2,083 (0.8%) in the no drug group, 12 of 256 (4.7%) in the aspirin group, 3 of 48 (6.3%) in the single APA group, and 4 of 48 (8.3%) in the multiple APA group (p<0.001). In the univariate analysis, post-ERCP bleeding was associated with age, pull-type sphincterotomy, and APA and was inversely associated with balloon dilation of the biliary orifice. In the multivariate analysis, pull-type sphincterotomy (odds ratio [OR], 7.829; 95% confidence interval [CI], 1.411 to 43.453; p=0.019) and country (Korea: OR, 0.124; 95% CI, 0.042 to 0.361; p<0.001) were associated with post-ERCP bleeding. Conclusions: The frequency of post-ERCP bleeding was statistically higher in patients on any APA within 6 days prior to ERCP. However, in the multivariate analysis, APA use was not associated with post-ERCP bleeding. Until a large, adequately powered study to detect differences is performed, caution is recommended when considering invasive procedures during ERCP in patients on APAs. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
23. Low Serum Pancreatic Amylase and Lipase Values Are Simple and Useful Predictors to Diagnose Chronic Pancreatitis.
- Author
-
Hyoung-Chul Oh, Chang-Il Kwon, El Hajj, Ihab I., Easler, Jeffrey J., Watkins, James, Fogel, Evan L., McHenry, Lee, Sherman, Stuart, Zimmerman, Michelle K., and Lehman, Glen A.
- Subjects
- *
AMYLASES , *LIPASES , *PANCREATITIS , *ENDOSCOPIC retrograde cholangiopancreatography , *SERUM - Abstract
Background/Aims: This study aimed to evaluate the diagnostic role of low serum amylase and lipase values in the detection of chronic pancreatitis. Methods: Patients underwent endoscopic retrograde cholangiopancreatography and were diagnosed with non-calcific chronic pancreatitis (NCCP; n=99) and calcific chronic pancreatitis (CCP; n=112). Patient serum amylase and lipase values were compared with those of healthy controls (H; n=170). Results: The median serum amylase (normal range, 19 to 86 U/L) and lipase values (7 to 59 U/L) (P25-P75) were 47.0 (39.8 to 55.3) and 25.0 (18.0 to 35.0) for H, 34.0 (24.5 to 49.0) and 19.0 (9.0 to 30.0) for NCCP, and 30.0 (20.0 to 40.8) and 10.0 (3.0 to 19.0) for CCP, respectively. The cutoff values with the highest diagnostic accuracy for discriminating NCCP from H were 40 U/L for amylase and 20 U/L for lipase, respectively, and for CCP from H were 38 U/L for amylase and 15 U/L for lipase, respectively. For the diagnosis of NCCP with a criterion of serum amylase <40 and lipase <20 U/L, the sensitivity, specificity, positive predictive value, and negative predictive values were 37.4%, 88.8%, 66.1%, and 70.9%, respectively. Conclusions: Serum amylase and/or lipase levels below the normal serum range are highly specific for chronic pancreatitis patients. Clinicians should not ignore low serum pancreatic enzyme values. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
24. Short- and long-term outcomes from percutaneous endoscopic gastrostomy with jejunal extension.
- Author
-
Ridtitid, Wiriyaporn, Lehman, Glen, Watkins, James, Mchenry, Lee, Fogel, Evan, Sherman, Stuart, Coté, Gregory, Lehman, Glen A, Watkins, James L, Fogel, Evan L, and Coté, Gregory A
- Subjects
- *
PERCUTANEOUS endoscopic gastrostomy , *JEJUNOILEAL bypass , *CHRONIC pancreatitis , *BODY mass index , *HOSPITAL care , *INPATIENT care , *PATIENTS , *PHYSIOLOGY , *JEJUNUM surgery , *PANCREATITIS , *ENTERAL feeding , *GASTROSTOMY , *LONGITUDINAL method , *HEALTH outcome assessment , *RESEARCH funding , *SURGICAL complications , *RETROSPECTIVE studies , *ACUTE diseases , *ENDOSCOPIC gastrointestinal surgery , *EQUIPMENT & supplies , *SURGERY - Abstract
Background: There is a paucity of data regarding the safety and efficacy of percutaneous endoscopic gastrostomy with jejunal extension (PEG-J). We evaluated adverse events related to PEG-J and determined the clinical impact of PEG-J in those with chronic pancreatitis (CP).Methods: This cohort study included all patients who underwent PEG-J placement in a tertiary-care academic medical center between 2010 and 2012. Main outcome measurements were (1) short- and long-term complications related to PEG-J and (2) changes in weight and hospitalizations during the 12-month period before and after PEG-J in the CP subgroup.Results: Of 102 patients undergoing PEG-J placement, the overall technical success rate was 97 %. During a median follow-up period of 22 months (1-46 months, n = 90), at least one tube malfunction occurred in 52/90 (58 %; 177 episodes) after a median of 53 days (3-350 days), requiring a median of two tube replacements. Short-term (<30 days) tube malfunction occurred in 28/90 (31 %) and delayed in 24/90 (27 %); these included dislodgement (29 %), clogging (26 %) and kinking (14 %). In the CP subgroup (n = 58), mean body weight (kg) (70 vs. 71, p = 0.06) and body mass index (kg/m2, 26 vs. 27, p = 0.05) increased post-PEG-J. Mean number of hospitalizations (5 vs. 2, p < 0.0001) and inpatient days per 12 months (22 vs. 12, p = 0.005) decreased.Conclusions: While we observed no major complications related to PEG-J, half of patients had at least one episode of tube malfunction. In the CP subgroup, jejunal feeding via PEG-J significantly reduced the number of hospitalizations and inpatients days, while improving nutritional parameters. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
25. Clinical response to dorsal duct drainage via the minor papilla in refractory obstructing chronic calcific pancreatitis.
- Author
-
Chang-Il Kwon, Gromski, Mark A., Sherman, Stuart, El Hajj, Ihab I., Easler, Jeffrey J., Watkins, James, McHenry, Lee, Lehman, Glen A., Fogel, Evan L., and Kwon, Chang-Il
- Subjects
- *
PANCREATIC duct , *PANCREATITIS treatment , *PAIN management , *SURGERY , *TREATMENT of calculi , *ABDOMINAL pain , *CALCULI , *PANCREATITIS , *REOPERATION , *RESEARCH funding , *SURGICAL stents , *DISEASE relapse , *ACUTE diseases , *DIGESTIVE system endoscopic surgery , *MEDICAL drainage , *DISEASE complications , *THERAPEUTICS - Abstract
Background and study aims Complete stone removal from the main pancreatic duct might not be achieved in all patients with obstructive chronic calcific pancreatitis. We report our results for endoscopic dorsal pancreatic duct (DPD) bypass of obstructing stones in the ventral pancreatic duct (VPD). Patients and methods 16 patients with obstructive chronic calcific pancreatitis were treated with a DPD bypass. Clinical success was defined as significant pain relief and no hospital admissions for pain management during the ongoing treatment period. Results Among 16 patients meeting entry criteria, 10 (62.5 %) had a history of unsuccessful endoscopic therapy, and 8 had failed extracorporeal shockwave lithotripsy (ESWL). Clinical success was achieved in 12 patients (75 %). Among these responders, 10 patients (83.3 %) had markedly improved or complete pain relief after the first stent placement, which persisted throughout the follow-up period; 11 patients (91.7 %) were able to discontinue their daily analgesics. Conclusions In selected patients with obstructive chronic calcific pancreatitis, the DPD bypass may be considered as a rescue endoscopic therapy, potentially obviating the need for surgery when standard endoscopic methods and ESWL fail. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
26. Time Sequence Evaluation of Biliary Stent Occlusion by Dissection Analysis of Retrieved Stents.
- Author
-
Kwon, Chang-Il, Gromski, Mark, Sherman, Stuart, Easler, Jeffrey, El Hajj, Ihab, Watkins, James, Fogel, Evan, McHenry, Lee, Lehman, Glen, Gromski, Mark A, Easler, Jeffrey J, El Hajj, Ihab I, Fogel, Evan L, and Lehman, Glen A
- Subjects
- *
SURGICAL stents , *ENDOSCOPIC retrograde cholangiopancreatography , *SURGICAL complications , *BIOFILMS , *TURBULENCE , *MEDICAL research , *CHOLESTASIS , *DISSECTION , *PLASTICS , *COMPLICATIONS of prosthesis , *SCANNING electron microscopy , *OPERATIVE surgery , *TIME , *STENOSIS ,BILIARY tract surgery - Abstract
Background and Aims: Multiple factors can affect the occlusion of plastic stents. Previous data demonstrate that side holes may induce more biofilm formation probably via microturbulence and bile flow disturbances that could lead to occlusion. These results, however, have not been replicated in subsequent clinical studies with different methods. The objective of this study is to evaluate the physical characteristics of plastic stent occlusion over time.Methods: This is a plastic stent sequential analysis study. Biliary stents removed via ERCP from February 24, 2015, to June 2, 2015, were included. One hundred and forty-eight retrieved straight-type plastic stents were longitudinally cut by a custom-made cutting device. These dissected stents were then evaluated in detail with regard to the location of stent occlusion and the stent patency period. Location of stent occlusive debris was the primary outcome in this study.Results: Biofilm formations and occlusions by debris were sequentially but separately tallied. Biofilm formations were initially seen around the side hole areas within 30 days and spread to the entire stent by 60 days. Then, occlusion process by debris was mainly initiated by 80 days and progressed to full occlusion by median of 90 days. Although some occlusions were also observed around the side hole areas within 30 days, affected areas were more widely observed after biofilm formation.Conclusions: This study is the first to attempt to describe the distribution of stent occlusions over time. These observations may help guide future stent development. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
27. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study.
- Author
-
Yaghoobi, Mohammad, Pauls, Qi, Durkalski, Valerie, Romagnuolo, Joseph, Fogel, Evan L., Tarnasky, Paul R., Aliperti, Giuseppe, Freeman, Martin L., Kozarek, Richard A., Jamidar, Priya A., Wilcox, Charles M., Elta, Grace H., Hawes, Robert H., Wood-Williams, April, and Cotton, Peter B.
- Subjects
- *
DUODENUM surgery , *PANCREATITIS diagnosis , *BILE duct diseases , *COMPARATIVE studies , *DUODENUM , *ENDOSCOPIC retrograde cholangiopancreatography , *LONGITUDINAL method , *MANOMETERS , *RESEARCH methodology , *MEDICAL cooperation , *PANCREATITIS , *PRESSURE , *PROGNOSIS , *RESEARCH , *SURGICAL stents , *SURGICAL complications , *EVALUATION research , *RANDOMIZED controlled trials , *DISEASE incidence , *ENDOSCOPIC gastrointestinal surgery , *DIAGNOSIS - Abstract
Background and Study Aim: Pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP) is a significant and potentially life-threatening adverse event and is common in patients with suspected sphincter of Oddi dysfunction (SOD). Here we aimed to identify predictors of the risk in this population.Patients and Methods: The Evaluating Predictors and Interventions in SOD (EPISOD) study prospectively enrolled 214 post-cholecystectomy patients with SOD type III in seven US centers. Patients were randomized, using a 2:1 allocation, to sphincterotomy or sham procedure, irrespective of the results of sphincter of Oddi manometry. Patients in the sphincterotomy arm who had elevated pancreatic sphincter pressure were randomized to biliary only or to dual (biliary and pancreatic) sphincterotomy. All but one patient received prophylactic pancreatic stents, but none received pharmacological prophylaxis. Post ERCP pancreatitis (PEP) was defined as acute pancreatitis within the subsequent 7 days. Blinded research coordinators at each site called patients at 1 week post-procedure.Results: PEP occurred in 26 patients, in 10.6 % (15/141) in the sphincterotomy arm and 15.1 % (11/73) in the sham arm; unadjusted relative risk 0.71 (95 % confidence interval [95 %CI] 0.34 - 1.46). PEP rate was not significantly different in patients who received sphincterotomy compared with those undergoing sham treatment. In addition, the proportion was not statistically different in those who received biliary sphincterotomy alone (12/94; 12.8 % [95 %CI 6.0 % - 19.5 %]) compared with dual sphincterotomy (3/47; 6.4 % [95 %CI 0.0 % - 13.4 %]). Multivariate analysis identified an interaction between duration of ERCP and sedation type (P < 0.02).Conclusion: The performance of biliary or dual sphincterotomy does not increase the risk of PEP in patients suspected of SOD. However, the high rate of PEP in patients with suspected SOD, despite pancreatic stenting in expert centers, is confirmed in this prospective study. The combined effect of duration of ERCP and sedation type on the development of PEP should be further explored.Clinicaltrials.gov registration: NCT00688662. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
28. Does Rectal Indomethacin Eliminate the Need for Prophylactic Pancreatic Stent Placement in Patients Undergoing High-Risk ERCP? Post hoc Efficacy and Cost-Benefit Analyses Using Prospective Clinical Trial Data.
- Author
-
Elmunzer, B Joseph, Higgins, Peter D R, Saini, Sameer D, Scheiman, James M, Parker, Robert A, Chak, Amitabh, Romagnuolo, Joseph, Mosler, Patrick, Hayward, Rodney A, Elta, Grace H, Korsnes, Sheryl J, Schmidt, Suzette E, Sherman, Stuart, Lehman, Glen A, and Fogel, Evan L
- Subjects
- *
INDOMETHACIN , *SURGICAL stents , *PANCREATIC surgery , *MEDICAL care costs , *ENDOSCOPIC retrograde cholangiopancreatography , *RANDOMIZED controlled trials , *LOGISTIC regression analysis , *COST effectiveness - Abstract
OBJECTIVES:A recent large-scale randomized controlled trial (RCT) demonstrated that rectal indomethacin administration is effective in addition to pancreatic stent placement (PSP) for preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in high-risk cases. We performed a post hoc analysis of this RCT to explore whether rectal indomethacin can replace PSP in the prevention of PEP and to estimate the potential cost savings of such an approach.METHODS:We retrospectively classified RCT subjects into four prevention groups: (1) no prophylaxis, (2) PSP alone, (3) rectal indomethacin alone, and (4) the combination of PSP and indomethacin. Multivariable logistic regression was used to adjust for imbalances in the prevalence of risk factors for PEP between the groups. Based on these adjusted PEP rates, we conducted an economic analysis comparing the costs associated with PEP prevention strategies employing rectal indomethacin alone, PSP alone, or the combination of both.RESULTS:After adjusting for risk using two different logistic regression models, rectal indomethacin alone appeared to be more effective for preventing PEP than no prophylaxis, PSP alone, and the combination of indomethacin and PSP. Economic analysis revealed that indomethacin alone was a cost-saving strategy in 96% of Monte Carlo trials. A prevention strategy employing rectal indomethacin alone could save approximately $150 million annually in the United States compared with a strategy of PSP alone, and $85 million compared with a strategy of indomethacin and PSP.CONCLUSIONS:This hypothesis-generating study suggests that prophylactic rectal indomethacin could replace PSP in patients undergoing high-risk ERCP, potentially improving clinical outcomes and reducing healthcare costs. A RCT comparing rectal indomethacin alone vs. indomethacin plus PSP is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
29. Intrathecal Narcotic Infusion Pumps for Intractable Pain of Chronic Pancreatitis: A Pilot Series.
- Author
-
Kongkam, Pradermchai, Wagner, Dennis L., Sherman, Stuart, Fogel, Evan L., Whittaker, Stephanie C., Watkins, James L., McHenry, Lee, and Lehman, Glen A.
- Subjects
- *
NARCOTICS , *INFUSION therapy , *PANCREATITIS , *PATIENTS , *PAIN - Abstract
OBJECTIVES:The aim of this study was to evaluate the efficacy of intrathecal narcotics pump (ITNP) as an alternative treatment for patients with pain from chronic pancreatitis (CP). ITNP offers the advantages of reversibility, lower total narcotic dose, and the pancreas remaining intact.METHODS:Thirteen patients (8 female, 5 male), with mean age 40.6 years (s.d. 9.6 years), who had experienced intractable upper abdominal pain from CP were reviewed. Each patient had multiple other failed treatment modalities, including partial pancreatic resection (n=6). They were offered ITNP after a successful intraspinal opioid trial. Etiologies of CP included idiopathy (n=3), cystic fibrosis (n=2), alcohol (n=2), and pancreas divisum (n=6).RESULTS:The median duration of severe, intractable pain prior to ITNP was 6 years (2–22 years). The median follow-up time after ITNP was 29 months (range, 7–94 months). The ITNP was in situ for a mean duration of 29 months (range, 0.5–94 months). Seven patients had pump exchange or removal for various reasons; improvement of pain at month 53 (n=1), meningitis (n=1), meningitis with subsequent replacement (n=1), pump failure at month 31, 68, 79, and 84 (n=4). There were no deaths. The mean pain score prior to implantation (score=8.3, s.d.=0.9) was significantly higher than 1 year after (score=2.7, s.d.=1.9) (P<0.01) and last follow-up (score=0.75, s.d.=2.1) (P<0.01). The median oral narcotic dose before and 1 year after ITNP were morphine sulfate equivalents 337.5 mg per day (range, 67.5–1,320) and 40 mg per day (range, 0–1,680), respectively (P<0.01). Two patients were considered failures, as they still require a high dosage of both oral and intrathecal medications to control their pain, despite significant pain-score improvement. One patient who was excluded due to meningitis was also considered a failure. Therefore, the overall success rate of ITNP based on an intention-to-treat analysis was 76.9% (10/13). The major complications of ITNP were central nervous system infection requiring pump removal (n=1), cerebrospinal fluid leak requiring laminectomy (n=1), and perispinal abscess with bacterial meningitis requiring pump removal (n=1).CONCLUSIONS:This study shows the many risks and benefits of ITNP. A longer follow-up is awaited; such pumps appear to be one alternative to aggressive surgical intervention. Failed ITNP trials leave other options open. Therapeutic trials directly comparing pancreatectomy, ITNP, and implanted nerve stimulators are of interest.Am J Gastroenterol 2009; 104:1249–1255; doi:10.1038/ajg.2009.54; published online 14 April 2009 [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
30. Annular Pancreas: Dramatic Differences Between Children and Adults
- Author
-
Zyromski, Nicholas J., Sandoval, John A., Pitt, Henry A., Ladd, Alan P., Fogel, Evan L., Mattar, Wissam E., Sandrasegaran, Kumar, Amrhein, David W., Rescorla, Fredrick J., Howard, Thomas J., Lillemoe, Keith D., and Grosfeld, Jay L.
- Subjects
- *
CEMENTUM annuli , *JUVENILE diseases , *STENOSIS , *DIAGNOSIS - Abstract
Background: Annular pancreas is rare; only 737 cases have been reported in the English literature. In addition, no large analysis has compared children and adults. Recently, prenatal diagnosis and advances in imaging have led to increased experience with this condition. Study Design: Data from 103 patients (48 children, 55 adults) with annular pancreas, managed from 1992 to 2006, were reviewed. Patients with isolated duodenal atresia, stenosis, or webs were excluded. Results: Median ages at diagnosis were 1 day in children and 47 years in adults. Annular pancreas was more common in girls and women (children, 58%; adults, 69%). Congenital anomalies were more frequent (p < 0.01) in children (71%) than in adults (16%); Down syndrome, cardiac, and intestinal anomalies were most common. Prenatal diagnosis was suspected in 56% of infants, and adults presented with pain (75%), vomiting (24%), pancreatitis (22%), or abnormal liver tests (11%). All children were managed with duodenal bypass. Children were more likely (p < 0.01) to require surgery for associated anomalies. In contrast, adults had fewer duodenal bypass procedures (24%) but more often required endoscopic pancreatobiliary procedures (67%), cholecystectomy (56%), and other pancreatobiliary surgery (20%; p < 0.01). Adults more commonly (p < 0.01) had pancreas divisum (29%) and pancreatobiliary neoplasia (11%). Five children (6%) with multiple anomalies died; all adults survived their operations. Late deaths occurred in 2 children (4%) with multiple anomalies and 3 adults (5%) with pancreatobiliary cancer. Conclusions: Annular pancreas is associated with a spectrum of disease that differs in children and adults. Congenital anomalies are more common in children with annular pancreas; complex pancreatobiliary disorders and malignancy are more frequent in adults. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
31. Risk Factors for Post-ERCP Pancreatitis: A Prospective Multicenter Study.
- Author
-
Chi-Liang Cheng, Sherman, Stuart, Watkins, James L., Barnett, Jeffrey, Freeman, Martin, Geenen, Joseph, Ryan, Michael, Parker, Harrison, Frakes, James T., Fogel, Evan L., Silverman, William B., Dua, Kulwinder S., Aliperti, Giuseppe, Yakshe, Paul, Uzer, Michael, Jones, Whitney, Goff, John, Lazzell-Pannell, Laura, Rashdan, Abdullah, and Temkit, M’hamed
- Subjects
- *
PANCREATITIS , *ENDOSCOPIC retrograde cholangiopancreatography , *ADRENOCORTICAL hormones , *SPHINCTERS , *GENDER , *PANCREATIC duct , *INJECTIONS , *DISEASE risk factors - Abstract
OBJECTIVES: Pancreatitis is the most common and serious complication of diagnostic and therapeutic ERCP. The aim of this study is to examine the potential patient- and procedure-related risk factors for post-ERCP pancreatitis in a prospective multicenter study. METHODS: A 160-variable database was prospectively collected by a defined protocol on patients undergoing diagnostic or therapeutic ERCP at 15 centers in the Midwest Pancreaticobiliary Group and participating in a randomized controlled study evaluating whether prophylactic corticosteroids will reduce the incidence of post-ERCP pancreatitis. Data were collected prior to the procedure, at the time of procedure, and 24–72 h after discharge. Post-ERCP pancreatitis was diagnosed and its severity graded according to consensus criteria. RESULTS: Of the 1,115 patients enrolled, diagnostic ERCP with or without sphincter of Oddi manometry (SOM) was performed in 536 (48.1%) and therapeutic ERCP in 579 (51.9%). Suspected sphincter of Oddi dysfunction (SOD) was the indication for the ERCP in 378 patients (33.9%). Pancreatitis developed in 168 patients (15.1%) and was graded mild in 112 (10%), moderate in 45 (4%), and severe in 11(1%). There was no difference in the incidence of pancreatitis or the frequency of investigated potential pancreatitis risk factors between the corticosteroid and placebo groups. By univariate analysis, the incidence of post-ERCP pancreatitis was significantly higher in 19 of 30 investigated variables. In the multivariate risk model, significant risk factors with adjusted odds ratios (OR) were: minor papilla sphincterotomy (OR: 3.8), suspected SOD (OR: 2.6), history of post-ERCP pancreatitis (OR: 2.0), age <60 yr (OR: 1.6), ≥2 contrast injections into the pancreatic duct (OR: 1.5), and trainee involvement (OR: 1.5). Female gender, history of recurrent idiopathic pancreatitis, pancreas divisum, SOM, difficult cannulation, and major papilla sphincterotomy (either biliary or pancreatic) were not multivariate risk factors for post-ERCP pancreatitis. CONCLUSION: This study emphasizes the role of patient factors (age, SOD, prior history of post-ERCP pancreatitis) and technical factors (number of PD injections, minor papilla sphincterotomy, and operator experience) as the determining high-risk predictors for post-ERCP pancreatitis. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
32. Facilitation of pancreatic duct cannulation using a new synthetic porcine secretin
- Author
-
Devereaux, Benedict M., Lehman, Glen A., Fein, Seymour, Phillips, Susan, Fogel, Evan L., and Sherman, Stuart
- Subjects
- *
CATHETERIZATION , *PANCREATIC secretions , *PEPTIDE hormones , *SECRETIN - Abstract
OBJECTIVES:Cannulation of the pancreatic duct at ERCP can represent a technical challenge, even to experienced pancreaticobiliary endoscopists. Secretin is a polypeptide hormone that increases the volume and bicarbonate content of pancreatic secretions. We report our single center experience in the use of a new synthetic porcine secretin (sPS) for the facilitation of cannulation of either the major or minor pancreatic orifice during ERCP.METHODS:Patients presenting for a variety of indications were enrolled. If identification or cannulation of the desired pancreatic duct was difficult, 0.2 μg/kg of sPS was administered i.v. Cannulation success or failure was recorded.RESULTS:Between March, 1999, and May, 2000, a total of 25 patients (seven men and 18 women) were enrolled. The most frequent indication (15 of 25 cases) was facilitation of dorsal pancreatic duct cannulation in patients with pancreas divisum. The overall rate of successful cannulation secretin administration was 24 of 25 cases (96%). No adverse events directly attributable to secretin were observed.CONCLUSIONS:The results of this study show that sPS is safe and efficacious in faciliting cannulation of either the major or minor pancreatic orifice at ERCP in the subset of patients who represent cannulation difficulties. Once commercially available, sPS can be added to the armamentarium of techniques to facilitate ERP. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.